Fiche centre
Amsterdam UMC, location VUmc
Amsterdam — Netherlands
Essais liés3clinical trials
VilleAmsterdamlocalisation
PaysNetherlandslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05834855
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Clemastine Fumarate | SEP | Phase 3 | NCT05338450 | RESTORE — Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis | TERMINATED |
| Rituximab | SEP | Phase 3 | NCT05834855 | Noisy Rebels — Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS | RECRUITING |
| WOC — The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis | SEP | À vérifier | NCT04478591 | WOC — The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis | COMPLETED |